Skip to main content
OpenTrials
Completed

NCT Number: NCT02841527

Gastric Bypass, Gastric Band or Sleeve Gastrectomy to Treat Obesity

Obesity is an increasing health problem in the United Kingdom (UK) and is predicted to worsen.

In the UK and worldwide the three most commonly performed operations are laparoscopic adjustable gastric banding ('BAND surgery'), laparoscopic gastric bypass ('BYPASS') and laparoscopic sleeve gastrectomy ('SLEEVE'). All lead to weight loss, but they are associated with different problems. This study (BYBANDSLEEVE) is a randomised trial with a target recruitment of 1341 patients in twelve hospitals and its aim is to compare the effectiveness, cost effectiveness and acceptability of BAND, BYPASS and SLEEVE surgery.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Heart of England NHS Foundation Trust, Birmingham, United Kingdom

Loading trial locations.

About this study

Obesity is an increasing health problem in the UK and one which is predicted to worsen. It is associated with many health problems that can shorten a person's life span and impair quality of life. Current national guidelines recommend that surgery is considered for the very overweight (morbidly obese) or for those remaining obese after trying other options.

In the UK and worldwide the three most commonly performed operations are laparoscopic adjustable gastric banding ('BAND surgery'), laparoscopic gastric bypass ('BYPASS') and laparoscopic sleeve gastrectomy ('SLEEVE'). All lead to weight loss, but they are associated with different problems. In the short term there are varying complications and inconvenience relating to the operation. In the longer term there are different outcomes relating to weight regain, symptoms and side effects of surgery. This study (BYBANDSLEEVE) is a randomised trial with a recruitment target of 1341 patients in twelve hospitals and its aim is to compare the effectiveness, cost effectiveness and acceptability of BAND, BYPASS and SLEEVE surgery. The process of randomisation will mean that participants have a chance of receiving one of the three procedures, so a fair comparison between them can be made.

The first phase (in two hospitals) will test the feasibility of recruitment and optimise information for patients to maximise trial recruitment. It will establish a core set of clinical outcomes to use to evaluate the surgery for morbid obesity. The second stage (in 12 hospitals) will recruit the full sample and follow up all participants for at least three years. The investigators will compare the effects of BAND, BYPASS AND SLEEVE surgery three years after randomisation on weight loss, a wide range of symptoms and aspects of quality of life. The investigators will also examine patients' detailed experiences during follow up, nutritional outcomes, short and long term surgical complications and National Health Service (NHS) value for money.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male or female patients
  • Over 18 years of age
  • Referred for bariatric surgery according to the National Institute for Health and Care Excellence (NICE) guidelines - BMI of 40kg/m2 or more, OR BMI of 35 kg/m2 to 40 kg/m2 and other significant disease (e.g. type 2 diabetes or high blood pressure) OR BMI of 30 kg/m2 or more and recent onset diabetes OR Asian family origin with lower BMI and recent onset diabetes, that could improve with weight loss
  • Has been or is willing to receive intensive management in a specialist tier 3 obesity service
  • Fit for anaesthesia and surgery
  • Committed to follow-up and able to complete quality of life questionnaires
  • Able to provide written informed consent.

Exclusion criteria

  • Previous gastric surgery or surgery for severe and complex obesity
  • Previous abdominal surgery or gastro-intestinal (GI) condition that precludes one or more of Band, Bypass or Sleeve
  • Large abdominal ventral hernia
  • Pregnancy (women who have given birth and women planning pregnancy will NOT be excluded)
  • Crohn's disease
  • Liver cirrhosis and portal hypertension
  • Systemic lupus erythematosis
  • Known silicone allergy
  • Hiatus hernia >5cm
  • Other clinical/psychological reason, to be specified
  • Active participation in another interventional research study which might interfere with By-Band-Sleeve

Treatment and study plan

Gastric Band

Procedure

Surgical intervention in which a band is inserted around the top of the stomach to reduce its size.

Gastric bypass

Procedure

Surgical intervention where a small pouch is made in the top of the stomach and a loop of bowel connected to this pouch to bypass the rest of the stomach.

Sleeve gastrectomy

Procedure

Surgical intervention which reduces the size of the stomach by about 75%, creating a narrow tube. It is done by stapling down the stomach and removing the remainder of the stomach.

Primary outcomes

  1. The proportion achieving loss of greater than 50% of excess weight at three years.

    Time frame: Three years

    The proportion achieving loss of greater than 50% of excess weight at three years (calculated as 100×[BMI at 3 years - BMI at randomisation1] / [BMI at randomisation - 25])

  2. Health-related Quality of Life (HRQoL)

    Time frame: Three years

    HRQoL at three 3 years, will be assessed using the EQ-5D-5L

Secondary outcomes

  1. Change in BMI over time adjusted for BMI at randomisation

    Time frame: Three years

    Change in BMI over time adjusted for BMI at randomisation

  2. Percentage weight loss at 3 years

    Time frame: Three years

    Percentage weight loss at 3 years

  3. Waist circumference at 3 years

    Time frame: Three years

    Waist circumference at 3 years

  4. Time taken from randomisation to reach first loss of at least 50% of excess BMI

    Time frame: Three years

    Time taken from randomisation to reach first loss of at least 50% of excess BMI

  5. Time taken from first losing 50% excess BMI to first relapse

    Time frame: Three years

    Time taken from first losing 50% excess BMI to first relapse (defined as weight re-gain such that the target of at least 50% of excess weight loss is no longer met)

  6. Generic and symptom specific Health-related Quality of Life (HRQOL)

    Time frame: Three years

    Impact of Weight on Quality of Life (IWQOL-Lite)

  7. Generic and symptom specific Health-related Quality of Life (HRQOL)

    Time frame: Three years

    The Gastrointestinal Quality of Life Index

  8. Generic and symptom specific Health-related Quality of Life (HRQOL)

    Time frame: Three years

    Eating Habits Questionnaire

  9. Generic and symptom specific Health-related Quality of Life (HRQOL)

    Time frame: Three years

    SF-12v2 Health Survey

  10. Generic and symptom specific Health-related Quality of Life (HRQOL)

    Time frame: Three years

    Hospital Anxiety and Depression Scale (HADS).

  11. Resource use to three years

    Time frame: Three years

    Use of health service resources over the three-year study period.

  12. Standard healthcare blood tests

    Time frame: Three years

    Standard NHS nutritional blood tests will be performed at each assessment.

  13. Dietary recall

    Time frame: Three years

    Measures of 24 hour recall eating using a standardised and validated interview process

  14. Binge eating behaviour

    Time frame: Three years

    Binge eating behaviour using a validated questionnaire

  15. Adverse health events

    Time frame: Three years

    Adverse health events including the need for re-operation and cross over between interventions

  16. Resolution of co-morbidities

    Time frame: Three years

    Resolution of co-morbidities at 3 years, including sleep apnoea, non alcoholic fatty liver disease, type-2 diabetes, hypertension and hyperlipidaemia.

  17. Time to resolution of co-morbidities

    Time frame: Three years

    Time to resolution of sleep apnoea, type-2 diabetes, hypertension and hyperlipidaemia

Sponsors and collaborators

Lead sponsor

University of Bristol

Other

Collaborators

  • University of Birmingham
  • University of Oxford

Registry information

Official study title

Gastric Bypass, Adjustable Gastric Banding or Sleeve Gastrectomy Surgery to Treat Severe and Complex Obesity: a Multi-centre Randomised Controlled Trial

Acronym: ByBandSleeve

Important dates

Study start
2012
Primary completion
2022
Study completion
2023
First posted
Jul 22, 2016
Registry last updated
May 12, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.